Deerfield Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-1,411,000
Closed -$38.8M – 132
2024
Q4
$38.8M Hold
1,411,000
– – 0.73% 34
2024
Q3
$40.6M Hold
1,411,000
– – 0.61% 34
2024
Q2
$35M Hold
1,411,000
– – 0.58% 38
2024
Q1
$45.4M Buy
1,411,000
+788,888
+127% +$29.3M 0.79% 31
2023
Q4
$25.3M Buy
+622,112
New +$22.9M 0.47% 43
2021
Q3
– Sell
-657,005
Closed -$45.3M – 142
2021
Q2
$45.3M Buy
+657,005
New +$50.1M 0.8% 40
2019
Q4
– Sell
-101,010
Closed -$15.4M – 86
2019
Q3
$15.4M Hold
101,010
– – 0.63% 50
2019
Q2
$13M Sell
101,010
-75,948
-43% -$9.01M 0.47% 64
2019
Q1
$20.8M Sell
176,958
-111,449
-39% -$11.2M 0.8% 41
2018
Q4
$26.5M Buy
288,407
+28,343
+11% +$2.87M 1.06% 36
2018
Q3
$29.2M Buy
260,064
+95,064
+58% +$10M 1.05% 36
2018
Q2
$15.2M Buy
165,000
+35,000
+27% +$3.4M 0.53% 69
2018
Q1
$13M Hold
130,000
– – 0.45% 75
2017
Q4
$12.2M Hold
130,000
– – 0.48% 61
2017
Q3
$13.2M Sell
130,000
-57,501
-31% -$5.02M 0.6% 56
2017
Q2
$14.3M Sell
187,501
-72,267
-28% -$6.08M 0.77% 37
2017
Q1
$22.4M Sell
259,768
-163,344
-39% -$11.8M 0.86% 43
2016
Q4
$27.2M Hold
423,112
– – 1.12% 33
2016
Q3
$27.4M Sell
423,112
-35,000
-8% -$1.97M 1.27% 27
2016
Q2
$25.4M Buy
458,112
+130,486
+40% +$6.56M 1% 38
2016
Q1
$13.7M Buy
327,626
+144,626
+79% +$6.71M 0.58% 50
2015
Q4
$11.5M Sell
183,000
-258,085
-59% -$13.2M 0.47% 62
2015
Q3
$18M Sell
441,085
-201,523
-31% -$11.6M 0.69% 52
2015
Q2
$33.1M Buy
+642,608
New +$34.1M 1.1% 30

Other funds holding LKFT

Deerfield Management's LKFT Position: Q1 2025 in Review

Deerfield Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2025, closing a stake of 1,411,000 shares — an estimated $38.8M sold.

Deerfield Management first reported a position in LKFT in Q2 2015 and held it in 24 quarters. The position peaked at $45.4M in Q1 2024. 83 funds tracked by Wall St. Rank hold LKFT as of Q1 2025.

  • Deerfield Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2025 after selling out during the quarter.
  • Deerfield Management sold 1,411,000 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2025, an estimated $38.8M.
  • Deerfield Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and held it in 24 quarters.
  • Deerfield Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $45.4M in Q1 2024.
  • 83 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2025.

Based on Deerfield Management's 13F filing for Q1 2025, filed 15 May 2025.